Evidence map›Paper›PMID 28273850›Full record

ArticleMarine drugs2017

Chitosan-Based Nanomedicine to Fight Genital Candida Infections: Chitosomes.

Toril Andersen, Ekaterina Mishchenko, Gøril Eide Flaten, Johanna U Ericson Sollid, Sofia Mattsson, Ingunn Tho, Nataša Škalko-Basnet

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Review
  3. Fungal-Derived Chitosan fromMaterials (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Review
  6. Lecithin and Chitosan as Building Blocks in Anti-Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  7. Vaginal Sheets withGels (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. New perspectives on the topical management of recurrent candidiasis.Drug delivery and translational research · 2021
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Toril AndersenDrug Transport and Delivery Research Group, Department of Pharmacy, Faculty of Health Sciences, University of Tromsø The Arctic University of Norway, 9037 Tromsø, Norway. toril_andersen@hotmail.com.
Ekaterina MishchenkoHost Microbe Interactions Research Group, Department of Medical Biology, Faculty of Health Sciences, University of Tromsø The Arctic University of Norway, 9037 Tromsø, Norway. ekaterina.mishchenko@uit.no.
Gøril Eide FlatenDrug Transport and Delivery Research Group, Department of Pharmacy, Faculty of Health Sciences, University of Tromsø The Arctic University of Norway, 9037 Tromsø, Norway. goril.flaten@uit.no.
Johanna U Ericson SollidHost Microbe Interactions Research Group, Department of Medical Biology, Faculty of Health Sciences, University of Tromsø The Arctic University of Norway, 9037 Tromsø, Norway. johanna.e.sollid@uit.no.
Sofia MattssonDepartment of Pharmacology and Clinical Neuroscience, Division of Clinical Pharmacology, Umeå University, SE-90187 Umeå, Sweden. sofia.mattsson@pharm.umu.se.
Ingunn ThoPersonalized Dosage Form Design Research Group, School of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway. ingunn.tho@farmasi.uio.no.
Nataša Škalko-BasnetDrug Transport and Delivery Research Group, Department of Pharmacy, Faculty of Health Sciences, University of Tromsø The Arctic University of Norway, 9037 Tromsø, Norway. natasa.skalko-basnet@uit.no.
UiT The Arctic University of Norway · NOUmeå University · SEUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaginal infections are associated with high recurrence, which is often due to a lack of efficient treatment of complex vaginal infections comprised of several types of pathogens, especially fungi and bacteria. Chitosan, a mucoadhesive polymer with known antifungal effect, could offer a great improvement in vaginal therapy; the chitosan-based nanosystem could both provide antifungal effects and simultaneously deliver antibacterial drugs. We prepared chitosan-containing liposomes, chitosomes, where chitosan is both embedded in liposomes and surface-available as a coating layer. For antimicrobial activity, we entrapped metronidazole as a model drug. To prove that mucoadhesivness alone is not sufficient for successful delivery, we used Carbopol-containing liposomes as a control. All vesicles were characterized for their size, zeta potential, entrapment efficiency, and in vitro drug release. Chitosan-containing liposomes were able to assure the prolonged release of metronidazole. Their antifungal activity was evaluated in a

Indexed as

AdhesivenessAdministration, IntravaginalAntifungal AgentsCandida albicansCandidiasisChitosanDrug CarriersDrug Delivery SystemsExcipientsFemaleHumansLiposomesNanomedicineParticle SizeVaginaAntifungal AgentsChitosanDrug CarriersExcipientsLiposomesCandida albicanschitosandrug deliveryliposomesmetronidazolevaginal therapy

Identifiers

PMID28273850
PMCPMC5367021
OpenAlexW2592278588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.